Protagenic Therapeutics, Inc.\new
PTIXOTCCIK 1022899HealthcareFiscal year ends Mar 31
Income statement
| Line item | Unit | Q3 FY20232023-09-30 | Q4 FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q1 FY20262025-06-30 | Q2 FY20262025-09-30 | Q3 FY20262025-12-31 | Q4 FY20262026-03-31 | Q1 FY20272026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $k | 0.0Revenue, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-14, accession 0001493152-24-045913.Report this figure | 0.0Revenue, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-31, accession 0001641172-25-001600. Derived: 12-month figure less the 9-month figure.Report this figure | 0.0Revenue, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-13, accession 0001641172-25-009923.Report this figure | 0.0Revenue, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2024-08-14, accession 0001493152-24-032349.Report this figure | 0.0Revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-14, accession 0001493152-24-045913.Report this figure | 0.0Revenue, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-31, accession 0001641172-25-001600. Derived: 12-month figure less the 9-month figure.Report this figure | 0.0Revenue, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-13, accession 0001641172-25-009923.Report this figure | 0.0Revenue, Q1 FY2026, three months to 2025-06-30$0. XBRL concept us-gaap:Revenues. 10-QT filed 2025-09-10, accession 0001641172-25-027041.Report this figure | 0.0Revenue, Q2 FY2026, three months to 2025-09-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-26, accession 0001493152-25-025201. Derived: 6-month figure less the 3-month figure.Report this figure | 0.0Revenue, Q3 FY2026, three months to 2025-12-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2026-03-09, accession 0001493152-26-009301. Derived: 9-month figure less the 6-month figure.Report this figure | 0.0Revenue, Q4 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:Revenues. 10-K filed 2026-08-14, accession 0001493152-26-038255. Derived: 12-month figure less the 9-month figure.Report this figure | not reported |
| Research and development | $k | 1,124Research and development, Q3 FY2023, three months to 2023-09-30$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0001493152-24-045913.Report this figure | 1,012Research and development, Q4 FY2023, three months to 2023-12-31$1.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-31, accession 0001641172-25-001600. Derived: 12-month figure less the 9-month figure.Report this figure | 1,461Research and development, Q1 FY2024, three months to 2024-03-31$1.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-13, accession 0001641172-25-009923.Report this figure | 19.1Research and development, Q2 FY2024, three months to 2024-06-30$19.1k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-QT filed 2025-09-10, accession 0001641172-25-027041.Report this figure | 17.0Research and development, Q3 FY2024, three months to 2024-09-30$17.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-26, accession 0001493152-25-025201.Report this figure | 135Research and development, Q4 FY2024, three months to 2024-12-31$134.6k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-03-09, accession 0001493152-26-009301.Report this figure | 880Research and development, Q1 FY2025, three months to 2025-03-31$880.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-13, accession 0001641172-25-009923.Report this figure | 394Research and development, Q1 FY2026, three months to 2025-06-30$394.1k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-19, accession 0001493152-26-039221.Report this figure | 273Research and development, Q2 FY2026, three months to 2025-09-30$273.2k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-26, accession 0001493152-25-025201.Report this figure | 154Research and development, Q3 FY2026, three months to 2025-12-31$153.8k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-03-09, accession 0001493152-26-009301.Report this figure | 80.8Research and development, Q4 FY2026, three months to 2026-03-31$80.8k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-08-14, accession 0001493152-26-038255. Derived: 12-month figure less the 9-month figure.Report this figure | 110Research and development, Q1 FY2027, three months to 2026-06-30$109.9k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-19, accession 0001493152-26-039221.Report this figure |
| Operating income | $k | (1,432)Operating income, Q3 FY2023, three months to 2023-09-30−$1.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0001493152-24-045913.Report this figure | (1,212)Operating income, Q4 FY2023, three months to 2023-12-31−$1.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0001641172-25-001600. Derived: 12-month figure less the 9-month figure.Report this figure | (1,738)Operating income, Q1 FY2024, three months to 2024-03-31−$1.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0001641172-25-009923.Report this figure | (322)Operating income, Q2 FY2024, three months to 2024-06-30−$321.8k. XBRL concept us-gaap:OperatingIncomeLoss. 10-QT filed 2025-09-10, accession 0001641172-25-027041.Report this figure | (355)Operating income, Q3 FY2024, three months to 2024-09-30−$355.4k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-26, accession 0001493152-25-025201.Report this figure | (401)Operating income, Q4 FY2024, three months to 2024-12-31−$401.4k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-03-09, accession 0001493152-26-009301.Report this figure | (1,448)Operating income, Q1 FY2025, three months to 2025-03-31−$1.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0001641172-25-009923.Report this figure | (1,208)Operating income, Q1 FY2026, three months to 2025-06-30−$1.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-19, accession 0001493152-26-039221.Report this figure | (1,114)Operating income, Q2 FY2026, three months to 2025-09-30−$1.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-26, accession 0001493152-25-025201.Report this figure | (925)Operating income, Q3 FY2026, three months to 2025-12-31−$925.1k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-03-09, accession 0001493152-26-009301.Report this figure | (120)Operating income, Q4 FY2026, three months to 2026-03-31−$120.3k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-14, accession 0001493152-26-038255. Derived: 12-month figure less the 9-month figure.Report this figure | (961)Operating income, Q1 FY2027, three months to 2026-06-30−$961.2k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-19, accession 0001493152-26-039221.Report this figure |
| Interest expense | $k | 32.0Interest expense, Q3 FY2023, three months to 2023-09-30$32.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-14, accession 0001493152-23-041032.Report this figure | 12.9Interest expense, Q4 FY2023, three months to 2023-12-31$12.9k. XBRL concept us-gaap:InterestExpense. 10-K/A filed 2024-05-14, accession 0001493152-24-019018. Derived: 12-month figure less the 9-month figure.Report this figure | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | not reported | not reported | not reported | 2.5Income tax, Q2 FY2024, three months to 2024-06-30$2.5k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-QT filed 2025-09-10, accession 0001641172-25-027041.Report this figure | (2.5)Income tax, Q3 FY2024, three months to 2024-09-30−$2.5k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-26, accession 0001493152-25-025201.Report this figure | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | (1,397)Net income, Q3 FY2023, three months to 2023-09-30−$1.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0001493152-24-045913.Report this figure | (1,676)Net income, Q4 FY2023, three months to 2023-12-31−$1.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0001641172-25-001600. Derived: 12-month figure less the 9-month figure.Report this figure | (1,724)Net income, Q1 FY2024, three months to 2024-03-31−$1.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-13, accession 0001641172-25-009923.Report this figure | (324)Net income, Q2 FY2024, three months to 2024-06-30−$324.4k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-03-09, accession 0001493152-26-009301.Report this figure | (582)Net income, Q3 FY2024, three months to 2024-09-30−$582.4k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-03-09, accession 0001493152-26-009301.Report this figure | (850)Net income, Q4 FY2024, three months to 2024-12-31−$850.3k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-03-09, accession 0001493152-26-009301.Report this figure | (1,440)Net income, Q1 FY2025, three months to 2025-03-31−$1.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-13, accession 0001641172-25-009923.Report this figure | (5,058)Net income, Q1 FY2026, three months to 2025-06-30−$5.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-19, accession 0001493152-26-039221.Report this figure | (869)Net income, Q2 FY2026, three months to 2025-09-30−$869.5k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-03-09, accession 0001493152-26-009301.Report this figure | 2,211Net income, Q3 FY2026, three months to 2025-12-31$2.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-03-09, accession 0001493152-26-009301.Report this figure | 5,084Net income, Q4 FY2026, three months to 2026-03-31$5.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-14, accession 0001493152-26-038255. Derived: 12-month figure less the 9-month figure.Report this figure | (964)Net income, Q1 FY2027, three months to 2026-06-30−$963.6k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-19, accession 0001493152-26-039221.Report this figure |
| Diluted EPS | $ per share | (0.32)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0001493152-24-045913.Report this figure | not reported | (5.44)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$5.44 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-13, accession 0001641172-25-009923.Report this figure | (0.06)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-QT filed 2025-09-10, accession 0001641172-25-027041.Report this figure | (0.11)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-26, accession 0001493152-25-025201.Report this figure | (0.16)Diluted EPS, Q4 FY2024, three months to 2024-12-31−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-03-09, accession 0001493152-26-009301.Report this figure | (2.75)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$2.75 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-13, accession 0001641172-25-009923.Report this figure | (1.37)Diluted EPS, Q1 FY2026, three months to 2025-06-30−$1.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-19, accession 0001493152-26-039221.Report this figure | (0.47)Diluted EPS, Q2 FY2026, three months to 2025-09-30−$0.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-26, accession 0001493152-25-025201.Report this figure | 1.14Diluted EPS, Q3 FY2026, three months to 2025-12-31$1.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-03-09, accession 0001493152-26-009301.Report this figure | not reported | (0.53)Diluted EPS, Q1 FY2027, three months to 2026-06-30−$0.53 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-19, accession 0001493152-26-039221.Report this figure |
| Basic EPS | $ per share | (0.32)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001493152-24-045913.Report this figure | not reported | (5.44)Basic EPS, Q1 FY2024, three months to 2024-03-31−$5.44 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0001641172-25-009923.Report this figure | (0.06)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-QT filed 2025-09-10, accession 0001641172-25-027041.Report this figure | (0.11)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-26, accession 0001493152-25-025201.Report this figure | (0.16)Basic EPS, Q4 FY2024, three months to 2024-12-31−$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-03-09, accession 0001493152-26-009301.Report this figure | (2.75)Basic EPS, Q1 FY2025, three months to 2025-03-31−$2.75 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0001641172-25-009923.Report this figure | (1.37)Basic EPS, Q1 FY2026, three months to 2025-06-30−$1.37 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-19, accession 0001493152-26-039221.Report this figure | (0.47)Basic EPS, Q2 FY2026, three months to 2025-09-30−$0.47 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-26, accession 0001493152-25-025201.Report this figure | 1.14Basic EPS, Q3 FY2026, three months to 2025-12-31$1.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-03-09, accession 0001493152-26-009301.Report this figure | not reported | (0.53)Basic EPS, Q1 FY2027, three months to 2026-06-30−$0.53 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-19, accession 0001493152-26-039221.Report this figure |
Balance sheet
| Line item | Unit | Q3 FY20232023-09-30 | FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | FY20242024-12-31 | Q1 FY20252025-03-31 | Q1 FY20262025-06-30 | Q2 FY20262025-09-30 | Q3 FY20262025-12-31 | FY20262026-03-31 | Q1 FY20272026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $m | 0.2Cash and equivalents, Q3 FY2023, at 2023-09-30$153.3k. XBRL concept us-gaap:Cash. 10-Q filed 2023-11-14, accession 0001493152-23-041032.Report this figure | 1.3Cash and equivalents, FY2023, at 2023-12-31$1.3m. XBRL concept us-gaap:Cash. 10-K filed 2025-03-31, accession 0001641172-25-001600.Report this figure | 0.8Cash and equivalents, Q1 FY2024, at 2024-03-31$831.8k. XBRL concept us-gaap:Cash. 10-Q filed 2024-05-15, accession 0001493152-24-019933.Report this figure | 0.9Cash and equivalents, Q2 FY2024, at 2024-06-30$924.6k. XBRL concept us-gaap:Cash. 10-Q filed 2024-08-14, accession 0001493152-24-032349.Report this figure | 1.1Cash and equivalents, Q3 FY2024, at 2024-09-30$1.1m. XBRL concept us-gaap:Cash. 10-Q filed 2024-11-14, accession 0001493152-24-045913.Report this figure | 1.8Cash and equivalents, FY2024, at 2024-12-31$1.8m. XBRL concept us-gaap:Cash. 10-Q filed 2025-05-13, accession 0001641172-25-009923.Report this figure | 0.0Cash and equivalents, Q1 FY2025, at 2025-03-31$14.5k. XBRL concept us-gaap:Cash. 10-K filed 2026-08-14, accession 0001493152-26-038255.Report this figure | 4.1Cash and equivalents, Q1 FY2026, at 2025-06-30$4.1m. XBRL concept us-gaap:Cash. 10-QT filed 2025-09-10, accession 0001641172-25-027041.Report this figure | 2.7Cash and equivalents, Q2 FY2026, at 2025-09-30$2.7m. XBRL concept us-gaap:Cash. 10-Q filed 2025-11-26, accession 0001493152-25-025201.Report this figure | 2.2Cash and equivalents, Q3 FY2026, at 2025-12-31$2.2m. XBRL concept us-gaap:Cash. 10-Q filed 2026-03-09, accession 0001493152-26-009301.Report this figure | 1.5Cash and equivalents, FY2026, at 2026-03-31$1.5m. XBRL concept us-gaap:Cash. 10-Q filed 2026-08-19, accession 0001493152-26-039221.Report this figure | 0.6Cash and equivalents, Q1 FY2027, at 2026-06-30$566.0k. XBRL concept us-gaap:Cash. 10-Q filed 2026-08-19, accession 0001493152-26-039221.Report this figure |
| Current assets | $m | 5.4Current assets, Q3 FY2023, at 2023-09-30$5.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-14, accession 0001493152-23-041032.Report this figure | 4.2Current assets, FY2023, at 2023-12-31$4.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-31, accession 0001641172-25-001600.Report this figure | 2.5Current assets, Q1 FY2024, at 2024-03-31$2.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0001493152-24-019933.Report this figure | 1.4Current assets, Q2 FY2024, at 2024-06-30$1.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0001493152-24-032349.Report this figure | 1.4Current assets, Q3 FY2024, at 2024-09-30$1.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001493152-24-045913.Report this figure | 1.9Current assets, FY2024, at 2024-12-31$1.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-13, accession 0001641172-25-009923.Report this figure | 0.1Current assets, Q1 FY2025, at 2025-03-31$89.1k. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-08-14, accession 0001493152-26-038255.Report this figure | 4.3Current assets, Q1 FY2026, at 2025-06-30$4.3m. XBRL concept us-gaap:AssetsCurrent. 10-QT filed 2025-09-10, accession 0001641172-25-027041.Report this figure | 2.9Current assets, Q2 FY2026, at 2025-09-30$2.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-26, accession 0001493152-25-025201.Report this figure | 2.3Current assets, Q3 FY2026, at 2025-12-31$2.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-03-09, accession 0001493152-26-009301.Report this figure | 1.5Current assets, FY2026, at 2026-03-31$1.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-19, accession 0001493152-26-039221.Report this figure | 0.7Current assets, Q1 FY2027, at 2026-06-30$709.9k. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-19, accession 0001493152-26-039221.Report this figure |
| Total assets | $m | 5.4Total assets, Q3 FY2023, at 2023-09-30$5.4m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-14, accession 0001493152-23-041032.Report this figure | 4.3Total assets, FY2023, at 2023-12-31$4.3m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-31, accession 0001641172-25-001600.Report this figure | 2.6Total assets, Q1 FY2024, at 2024-03-31$2.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0001493152-24-019933.Report this figure | 1.5Total assets, Q2 FY2024, at 2024-06-30$1.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0001493152-24-032349.Report this figure | 1.5Total assets, Q3 FY2024, at 2024-09-30$1.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001493152-24-045913.Report this figure | 2.0Total assets, FY2024, at 2024-12-31$2.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0001641172-25-009923.Report this figure | 0.1Total assets, Q1 FY2025, at 2025-03-31$89.1k. XBRL concept us-gaap:Assets. 10-K filed 2026-08-14, accession 0001493152-26-038255.Report this figure | 6.5Total assets, Q1 FY2026, at 2025-06-30$6.5m. XBRL concept us-gaap:Assets. 10-QT filed 2025-09-10, accession 0001641172-25-027041.Report this figure | 5.0Total assets, Q2 FY2026, at 2025-09-30$5.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-26, accession 0001493152-25-025201.Report this figure | 4.4Total assets, Q3 FY2026, at 2025-12-31$4.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-03-09, accession 0001493152-26-009301.Report this figure | 3.7Total assets, FY2026, at 2026-03-31$3.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-19, accession 0001493152-26-039221.Report this figure | 2.8Total assets, Q1 FY2027, at 2026-06-30$2.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-19, accession 0001493152-26-039221.Report this figure |
| Current liabilities | $m | 1.3Current liabilities, Q3 FY2023, at 2023-09-30$1.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-14, accession 0001493152-23-041032.Report this figure | 0.7Current liabilities, FY2023, at 2023-12-31$655.3k. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-31, accession 0001641172-25-001600.Report this figure | 0.4Current liabilities, Q1 FY2024, at 2024-03-31$446.1k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0001493152-24-019933.Report this figure | 0.7Current liabilities, Q2 FY2024, at 2024-06-30$674.6k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0001493152-24-032349.Report this figure | 0.8Current liabilities, Q3 FY2024, at 2024-09-30$789.3k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001493152-24-045913.Report this figure | 0.9Current liabilities, FY2024, at 2024-12-31$942.8k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-13, accession 0001641172-25-009923.Report this figure | 5.0Current liabilities, Q1 FY2025, at 2025-03-31$5.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-08-14, accession 0001493152-26-038255.Report this figure | 10.5Current liabilities, Q1 FY2026, at 2025-06-30$10.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-QT filed 2025-09-10, accession 0001641172-25-027041.Report this figure | 9.7Current liabilities, Q2 FY2026, at 2025-09-30$9.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-26, accession 0001493152-25-025201.Report this figure | 6.8Current liabilities, Q3 FY2026, at 2025-12-31$6.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-03-09, accession 0001493152-26-009301.Report this figure | 1.0Current liabilities, FY2026, at 2026-03-31$1.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-19, accession 0001493152-26-039221.Report this figure | 1.1Current liabilities, Q1 FY2027, at 2026-06-30$1.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-19, accession 0001493152-26-039221.Report this figure |
| Total liabilities | $m | 1.3Total liabilities, Q3 FY2023, at 2023-09-30$1.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-14, accession 0001493152-23-041032.Report this figure | 0.7Total liabilities, FY2023, at 2023-12-31$655.3k. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-31, accession 0001641172-25-001600.Report this figure | 0.4Total liabilities, Q1 FY2024, at 2024-03-31$446.1k. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-15, accession 0001493152-24-019933.Report this figure | 0.7Total liabilities, Q2 FY2024, at 2024-06-30$674.6k. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0001493152-24-032349.Report this figure | 0.8Total liabilities, Q3 FY2024, at 2024-09-30$789.3k. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001493152-24-045913.Report this figure | 0.9Total liabilities, FY2024, at 2024-12-31$942.8k. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-13, accession 0001641172-25-009923.Report this figure | 5.0Total liabilities, Q1 FY2025, at 2025-03-31$5.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-08-14, accession 0001493152-26-038255.Report this figure | 10.5Total liabilities, Q1 FY2026, at 2025-06-30$10.5m. XBRL concept us-gaap:Liabilities. 10-QT filed 2025-09-10, accession 0001641172-25-027041.Report this figure | 9.7Total liabilities, Q2 FY2026, at 2025-09-30$9.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-26, accession 0001493152-25-025201.Report this figure | 6.8Total liabilities, Q3 FY2026, at 2025-12-31$6.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-03-09, accession 0001493152-26-009301.Report this figure | 1.0Total liabilities, FY2026, at 2026-03-31$1.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-19, accession 0001493152-26-039221.Report this figure | 1.1Total liabilities, Q1 FY2027, at 2026-06-30$1.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-19, accession 0001493152-26-039221.Report this figure |
| Shareholders' equity | $m | 4.2Shareholders' equity, Q3 FY2023, at 2023-09-30$4.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0001493152-24-045913.Report this figure | 3.7Shareholders' equity, FY2023, at 2023-12-31$3.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-13, accession 0001641172-25-009923.Report this figure | (1.8)Shareholders' equity, Q1 FY2024, at 2024-03-31−$1.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-08-14, accession 0001493152-26-038255.Report this figure | (1.8)Shareholders' equity, Q2 FY2024, at 2024-06-30−$1.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-03-09, accession 0001493152-26-009301.Report this figure | (2.5)Shareholders' equity, Q3 FY2024, at 2024-09-30−$2.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-03-09, accession 0001493152-26-009301.Report this figure | (3.3)Shareholders' equity, FY2024, at 2024-12-31−$3.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-03-09, accession 0001493152-26-009301.Report this figure | (5.0)Shareholders' equity, Q1 FY2025, at 2025-03-31−$5.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-19, accession 0001493152-26-039221.Report this figure | (4.0)Shareholders' equity, Q1 FY2026, at 2025-06-30−$4.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-19, accession 0001493152-26-039221.Report this figure | (4.7)Shareholders' equity, Q2 FY2026, at 2025-09-30−$4.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-03-09, accession 0001493152-26-009301.Report this figure | (2.4)Shareholders' equity, Q3 FY2026, at 2025-12-31−$2.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-03-09, accession 0001493152-26-009301.Report this figure | 2.6Shareholders' equity, FY2026, at 2026-03-31$2.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-19, accession 0001493152-26-039221.Report this figure | 1.7Shareholders' equity, Q1 FY2027, at 2026-06-30$1.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-19, accession 0001493152-26-039221.Report this figure |
Cash flow
| Line item | Unit | Q3 FY20232023-09-30 | Q4 FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q1 FY20262025-06-30 | Q2 FY20262025-09-30 | Q3 FY20262025-12-31 | Q4 FY20262026-03-31 | Q1 FY20272026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $k | (656)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$655.8k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001493152-24-045913. Derived: 9-month figure less the 6-month figure.Report this figure | (1,144)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-31, accession 0001641172-25-001600. Derived: 12-month figure less the 9-month figure.Report this figure | (1,659)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0001641172-25-009923.Report this figure | (246)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$246.4k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-QT filed 2025-09-10, accession 0001641172-25-027041.Report this figure | (186)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$185.7k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001493152-24-045913. Derived: 9-month figure less the 6-month figure.Report this figure | (820)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$819.8k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-31, accession 0001641172-25-001600. Derived: 12-month figure less the 9-month figure.Report this figure | (1,068)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0001641172-25-009923.Report this figure | (1,751)Operating cash flow, Q1 FY2026, three months to 2025-06-30−$1.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-19, accession 0001493152-26-039221.Report this figure | (812)Operating cash flow, Q2 FY2026, three months to 2025-09-30−$811.5k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-26, accession 0001493152-25-025201. Derived: 6-month figure less the 3-month figure.Report this figure | (510)Operating cash flow, Q3 FY2026, three months to 2025-12-31−$509.7k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-03-09, accession 0001493152-26-009301. Derived: 9-month figure less the 6-month figure.Report this figure | 266Operating cash flow, Q4 FY2026, three months to 2026-03-31$265.5k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-14, accession 0001493152-26-038255. Derived: 12-month figure less the 9-month figure.Report this figure | (944)Operating cash flow, Q1 FY2027, three months to 2026-06-30−$944.3k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-19, accession 0001493152-26-039221.Report this figure |
| Capital expenditure | $k | not reported | 94.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$94.0k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2025-03-31, accession 0001641172-25-001600. Derived: 12-month figure less the 9-month figure.Report this figure | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
Shares
| Line item | Unit | Q1 FY20232023-03-31 | Q2 FY20232023-06-30 | Q3 FY20232023-09-30 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q1 FY20262025-06-30 | Q2 FY20262025-09-30 | Q3 FY20262025-12-31 | Q1 FY20272026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted shares (weighted) | k shares | 4,318 | 4,331 | 4,331 | 317 | 5,396 | 5,396 | 5,396 | 523 | 3,701 | 1,849 | 1,935 | 1,810 |
Shares outstanding: 1.81m at Aug 19, 2026, from the cover of the 10-Q filed Aug 19, 2026.
Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. Listed shows no prices and gives no investment advice.